The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein

Journal of Virology

Volumn 85, Issue 13, 2011, Pages 6334-6342

  Zheng, Yan ^a   Martín, Claudia Sasṕnchez San ^a   Qin, Zhao ling ^a,b   Kielian, Margaret ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCOPROTEIN E1; HISTIDINE; MEMBRANE FUSION PROTEIN; E1 GLYCOPROTEIN, SEMLIKI FOREST VIRUS; MEMBRANE PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

ACIDITY; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; IN VITRO STUDY; MEMBRANE FUSION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN INTERACTION; SEMLIKI FOREST ALPHAVIRUS; VIRUS ATTACHMENT; VIRUS MUTANT; WILD TYPE; ALPHA VIRUS; ANIMAL; CHEMISTRY; GENETICS; HAMSTER; METABOLISM; MUTATION; PATHOGENICITY; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE;

ALPHAVIRUS; ANIMALS; CRICETINAE; HISTIDINE; HYDROGEN-ION CONCENTRATION; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MUTATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SEMLIKI FOREST VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS;

EID: 80052056371     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00596-11     Document Type: Article

References (40)

1. Aguilar, P. V., et al. 2004. Endemic Venezuelan equine encephalitis in northern Peru. Emerg. Infect. Dis. 10:880-888.
2. Blommel, P. G., and B. G. Fox. 2007. A combined approach to improving large-scale production of tobacco etch virus protease. Protein Expr. Purif. 55:53-68.
3. Bressanelli, S., et al. 2004. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23:728-738.
4. Centers for Disease Control and Prevention. 1992. Arboviral diseases-United States, 1991. MMWR Morb. Mort. Wk. Rep. 41:545-548.
5. Centers for Disease Control and Prevention. 1994. Arbovirus disease-United States, 1993. MMWR Morb. Mort. Wk. Rep. 43:385-387.
6. Chanel-Vos, C., and M. Kielian. 2004. A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion. J. Virol. 78:13543-13552.
7. Chanel-Vos, C., and M. Kielian. 2006. Second-site revertants of a Semliki Forest virus fusion-block mutation reveal the dynamics of a class II membrane fusion protein. J. Virol. 80:6115-6122.
8. DeLano, W. L. 2002. The PyMOL user's manual. DeLano Scientific, San Carlos, CA.
9. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132.
10. Enserink, M. 2007. Infectious diseases. Chikungunya: no longer a third world disease. Science 318:1860-1861.
11. Gibbons, D. L., et al. 2004. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427:320- 325.
12. Glomb-Reinmund, S., and M. Kielian. 1998. fus-1, a pH shift mutant of Semliki Forest virus, acts by altering spike subunit interactions via a mutation in the E2 subunit. J. Virol. 72:4281-4287.
13. Griffin, D. E. 2007. Alphaviruses, p. 1023-1067. In D. M. Knipe and P. M. Howley (ed.), Fields virology, fifth ed., vol. 1. Lippincott Williams & Wilkins, Philadelphia, PA.
14. Kampmann, T., D. S. Mueller, A. E. Mark, P. R. Young, and B. Kobe. 2006. The role of histidine residues in low-pH-mediated viral membrane fusion. Structure 14:1481-1487.
15. Kaufmann, B., et al. 2006. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proc. Natl. Acad. Sci. U. S. A. 103: 12400-12404.
16. Kielian, M., C. Chanel-Vos, and M. Liao. 2010. Alphavirus entry and membrane fusion. Viruses 2:796-825.
17. Kielian, M., S. Jungerwirth, K. U. Sayad, and S. DeCandido. 1990. Biosynthesis, maturation, and acid activation of the Semliki Forest virus fusion protein. J. Virol. 64:4614-4624.
18. Kuhn, R. J. 2007. Togaviridae: the viruses and their replication, p. 1001- 1022. In D. M. Knipe and P. M. Howley (ed.), Fields virology, fifth ed., vol. Lippincott Williams & Wilkins, Philadelphia, PA
19. Lescar, J., et al. 2001. The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 105:137-148.
20. Li, L., J. Jose, Y. Xiang, R. J. Kuhn, and M. G. Rossmann. 2010. Structural changes of envelope proteins during alphavirus fusion. Nature 468:705-708.
21. Liao, M., and M. Kielian. 2005. Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus-membrane fusion. J. Cell Biol. 171:111-120.
22. Liao, M., and M. Kielian. 2006. Functions of the stem region of the Semliki Forest virus fusion protein during virus fusion and assembly. J. Virol. 80: 11362-11369.
23. Liao, M., C. Saspacute;nchez-San Martin, A. Zheng, and M. Kielian. 2010. In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J. Virol. 84:5730-5740.
24. Liu, C. Y., C. Besanceney, Y. Song, and M. Kielian. 2010. Pseudorevertants of a Semliki Forest virus fusion-blocking mutation reveal a critical interchain interaction in the core trimer. J. Virol. 84:11624-11633.
25. Mercer, J., M. Schelhaas, and A. Helenius. 2010. Virus entry by endocytosis. Annu. Rev. Biochem. 79:803-833.
26. Modis, Y., S. Ogata, D. Clements, and S. C. Harrison. 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature 427:313-319.
27. Moore, J. P., and R. W. Doms. 2003. The entry of entry inhibitors: a fusion of science and medicine. Proc. Natl. Acad. Sci. U. S. A. 100:10598-10602.
28. Nayak, V., et al. 2009. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J. Virol. 83:4338-4344.
29. Nybakken, G. E., et al. 2005. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437:764-769.
30. Qin, Z. L., Y. Zheng, and M. Kielian. 2009. Role of conserved histidine residues in the low-pH dependence of the Semliki Forest virus fusion protein. J. Virol. 83:4670-4677.
31. Roussel, A., et al. 2006. Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure 14:75-86.
32. Salminen, A., J. M. Wahlberg, M. Lobigs, P. Liljeström, and H. Garoff. 1992. Membrane fusion process of Semliki Forest virus II: cleavage-dependent reorganization of the spike protein complex controls virus entry. J. Cell Biol. 116:349-357.
33. Saspacute;nchez-San Martin, C., C. Y. Liu, and M. Kielian. 2009. Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol. 17: 514-521.
34. Saspacute;nchez-San Martin, C., H. Sosa, and M. Kielian. 2008. A stable prefusion intermediate of the alphavirus fusion protein reveals critical features of class II membrane fusion. Cell Host Microbe 4:600-608.
35. Schwartz, O., and M. L. Albert. 2010. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 8:491-500.
36. Thompson, B. S., et al. 2009. A therapeutic antibody against West Nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog. 5:e1000453.
37. Voss, J. E., et al. 2010. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 468:709-712.
38. Wahlberg, J. M., W. A. M. Boere, and H. Garoff. 1989. The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation. J. Virol. 63:4991-4997.
39. Weaver, S. C., and A. D. Barrett. 2004. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat. Rev. Microbiol. 2:789- 801.
40. Zhang, X., M. Fugere, R. Day, and M. Kielian. 2003. Furin processing and proteolytic activation of Semliki Forest virus. J. Virol. 77:2981-2989.